Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,461 signal articles · 225 in last 24h · 132,928 total before filter · latest 1h ago
225last 24h
1161last 7d
205● bullish (7d)
122● bearish (7d)
208publishers
AllMacro281Earnings421M&A73Regulatory22Product10Analyst20
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
New York City Launches Sweeping Investigation Into Polymarket and Kalshi
The Wall Street Journal21d agobearish
New York City Launches Sweeping Investigation Into Polymarket and Kalshi

The New York City Council is investigating four prediction markets for alleged deceptive marketing practices and targeting minors, opening a new front in the bitter, state-by-state legal war over prediction-market regulation. City Council Speaker Julie Menin sent letters to Polymarket, Kalshi, Coinbase and Gemini Titan, all of which have a presence in New York City, on Aug. 11 seeking answers about how the companies comply with consumer protection laws. In a letter addressed to Polymarket founder and Chief Executive Shayne Coplan, Menin asked for details about Polymarket promotional videos that appeared to depict fake trades and promoted insider trading on social media.

Meta Platforms (META) Opens AI Models As $1 Billion Fund And Lawsuits Add Pressure
Simply Wall St.22d agobearish
Meta Platforms (META) Opens AI Models As $1 Billion Fund And Lawsuits Add Pressure

Meta Platforms (NasdaqGS:META) is pushing to open source superintelligent AI models and has launched Muse Glimmer as part of this effort. Mark Zuckerberg outlined a plan to make advanced AI widely accessible rather than keeping it locked behind premium services. Meta announced a US$1b fund aimed at supporting communities located near its data centers. The 9th Circuit allowed thousands of social media addiction lawsuits against Meta to proceed, increasing legal and regulatory pressure on the...

Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
Insider Monkey23d agoneutral
Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?

Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo authorization for its OTTAVA robotic surgical system. The authorization represents an important milestone for J&J’s MedTech ambitions, but the company is entering a market in which Intuitive Surgical (NASDAQ:ISRG) already has an extensive installed base, established surgeon […]

Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuits
Simply Wall St.26d agobearish
Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuits

Johnson & Johnson (NYSE: JNJ) agreed to a US$5.5b settlement to resolve tens of thousands of talc baby powder lawsuits. The deal ends decades of litigation over alleged health risks tied to the company’s talc-based products. The settlement follows years of high profile trials and failed bankruptcy attempts related to the talc claims. This resolution removes a long running legal overhang and brings more clarity for Johnson & Johnson investors. Consider broadening your research to other large...

What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?
Simply Wall St.26d agobearish
What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?

Boston Scientific (NYSE: BSX) has initiated multiple product recalls covering cardiac ablation generators and vascular access sheaths due to labeling discrepancies and air embolism risks. The recalls affect a broad mix of devices used in cardiac and vascular procedures across several international markets. Regulators and hospitals are assessing the implications for device safety protocols, clinical workflows, and future use of the impacted products. Product safety questions can prompt...

Apple (AAPL) Seeks Injunction In AI Trade Secret Lawsuit
Simply Wall St.26d agobearish
Apple (AAPL) Seeks Injunction In AI Trade Secret Lawsuit

Apple (NasdaqGS:AAPL) has filed a lawsuit against OpenAI alleging misappropriation of confidential AI and hardware technology trade secrets. The complaint seeks a preliminary injunction that Apple says is needed to prevent irreparable harm to its core AI and device development work. The case could bring internal details of Apple's AI research, product security practices, and development processes into public view. Legal and competitive risks around AI intellectual property are back in focus...

Rackspace (RXT) Stock Still Looks Undervalued After Fraud Lawsuit News
Simply Wall St.26d agobearish
Rackspace (RXT) Stock Still Looks Undervalued After Fraud Lawsuit News

Rackspace Technology stock has delivered a very strong run year to date, yet its valuation checks still point to shares screening on the cheap side rather than fully pricing in that move. Year to date the share price is up 394.7%, which puts a lot more weight on whether current expectations for the business can hold. Investor focus is split between the potential upside from Rackspace Technology’s push into enterprise and sovereign AI infrastructure and the valuation risk tied to multiple...

Alibaba Group Holding (BABA) Faces A Lawsuit, Is The Stock Still Cheap?
Simply Wall St.26d agobearish
Alibaba Group Holding (BABA) Faces A Lawsuit, Is The Stock Still Cheap?

Alibaba Group Holding (NYSE:BABA) is back in the spotlight after Rosen Law Firm filed a class action lawsuit covering investors who bought the stock between June 26, 2025 and June 24, 2026. See our latest analysis for Alibaba Group Holding. Recent AI announcements, including the Qwen3.8 Max model and reports of potential automotive use cases, have helped Alibaba Group Holding’s 30 day share price return reach 29.21%. However, the year to date share price return remains down 18.58% and the 5...

Is Bloom Energy (BE) Undervalued Following The Lawsuit And Short Seller Report?
Simply Wall St.27d agobearish
Is Bloom Energy (BE) Undervalued Following The Lawsuit And Short Seller Report?

Bloom Energy (BE) is back in focus after a class action lawsuit was filed on July 31, 2026, following a short seller report on its scandium sourcing and a same day stock price decline. See our latest analysis for Bloom Energy. Recent events around Bloom Energy have played out against a backdrop of sharp share price swings, with the stock posting a 7 day share price return of 43.10% but a 30 day share price return down 20.58%. Despite this volatility, the year to date share price return of...

FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Review
The Wall Street Journal28d agoneutral
FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Review

The Food and Drug Administration approved Moderna’s mRNA-based flu vaccine for adults ages 50 and older, clearing the first shot of its kind after a review process that nearly collapsed in February. The vaccine, called mFlusiva, uses the same mRNA technology as Moderna’s Covid-19 shots. It could reach pharmacies in time for the coming flu season, which typically starts in the fall.

Lululemon (LULU) Faces California Lawsuit Over Alleged Misleading Discount Prices
Simply Wall St.28d agobearish
Lululemon (LULU) Faces California Lawsuit Over Alleged Misleading Discount Prices

Lululemon athletica (NasdaqGS:LULU) is facing a consumer lawsuit in California that challenges its use of reference prices on discounted items. The complaint alleges that Lululemon used former prices that did not reflect actual recent selling prices, creating the appearance of larger discounts. The case adds to broader legal scrutiny of how major retailers communicate pricing and promotions to shoppers. Lululemon athletica has built its brand around premium athletic and leisure apparel,...

Philip Morris International (PM) Faces Brazil Lawsuit Pressure, Is The Upside Already Priced In?
Simply Wall St.28d agobearish
Philip Morris International (PM) Faces Brazil Lawsuit Pressure, Is The Upside Already Priced In?

Philip Morris International (NYSE:PM) is back in focus after Brazil’s landmark public health lawsuit moved a step closer to a liability ruling, putting long running legal risks alongside fresh investment and earnings data. See our latest analysis for Philip Morris International. The share price of Philip Morris International has pulled back in the past week with a 7 day share price return of 6.6% in the red, even after a 90 day share price return of 9.6% and a 1 year total shareholder return...